We have followed a general plan for the routine evaluation and management of an adult patient who presents with a parotid mass, as illustrated in the algorithm depicted in Figure 64-1. For further information on this subject, the reader is referred to two recently published, concise and excellent

History (pain or rapid growth, suggest malignancy)

Physical Exam (facial paresis skin involvement suggest malignancy)

CT scan FNA biopsy

Non-Neoplastic Disease


Further E & M as appropriate

Parotid Neoplasm suspected

Further E & M as appropriate

Superficial Lobe Parotidectomy with permanent section histopathology ("Grand Biopsy")

Benign neoplasm

T1 or T2

low-grade malignant neoplasm

T1 or T2 highgrade or

T3, Malignant Neoplasm no extra parotid spread

T4 malignant neoplasm with extraparotid spread

No further treatment (if not a recurrent tumor)

T1 or T2 highgrade or

T3, Malignant Neoplasm no extra parotid spread

T4 malignant neoplasm with extraparotid spread

Figure 64-1 Routine pathway for evalutation and management of a parotid mass in an adult patient.



Bailey—CHAPTER 64

1. Atula T, Grenman R, Laippala P, Klemi PJ. Fine-needle aspiration biopsy in the diagnosis of parotid gland lesions: evaluation of 438 biopsies. Diagn Cytopathol 1996;15:185

2. Boles R. Needle biopsy of salivary gland tumors. In: Snow JB Jr, ed. Controversy in Otolaryngology. Philadelphia: WB Saunders; 1980:87-91

3. Truelson JM. Controversies in salivary gland disease. In: Bailey BJ, ed. Head and Neck Surgery—(Otolaryngology. 2nd Ed. Philadelphia: Lippincott-Raven; 1998:851-857

4. Johns ME. Parotid mass. In: Holt GR, Mattox DE, Gates GA, eds. Decision Making in Otolaryngology. BC Decker; 1984:92-93

5. McGuirt WF, Keyes JW Jr, Greven KM, et al. Preoperative identification of benign versus malignant parotid masses: a comparative study including positron emission tomography. Laryngoscope 1995;105:579

6. Weber RS, Eisele DW, El-Naggar A, et al. Contemporary classification of salivary gland tumors: fine needle aspiration cytology (FNA). In: Gluckman JL, ed. Renewal of Certification Study Guide in Otolaryngology—Head and Neck Surgery. Kendall/Hunt; 1998:548

7. Becker T. Salivary gland imaging. In: Bailey BJ, ed. Head and Neck Surgery—Otolaryngology. 2nd Ed. Philadelphia: Lippincott-Raven; 1998:541-559

8. Barsotti JB, Westesson PL, Coniglio JU. Superiority of magnetic resonance over computed tomography for imaging parotid tumor. Ann OtolRhinolLaryngol 1994;103:737-740

9. Som PM, Shugar JMA, Sacher M, et al. Benign and malignant parotid pleomorphic adenomas: CT and MR studies. J Com-put Assist Tomogr 1988;12:65-69

10. Mees K, Vogl T, Kellermann O. Magnetic resonance tomography in tumors of the salivary glands—a diagnostic advantage? Laryngol Rhinol Otol (Stuttg) 1988;67:355-361

11. Mirich DR, McArdle CB, Kulkarli MV. Benign pleomorphic adenomas of the salivary gland. Surface coil MR imaging versus CT. J Comput Assist Tomogr 1987;11:620-623

12. Teresi LM, Lufkin RB, Wortham DG, et al. Parotid masses: MR imaging. Radiology 1987;163:405-409

13. Eisele DW, Johns ME. Salivary gland neoplasms. In: Bailey BJ, ed. Head and Neck Surgery—Otolaryngology. 2nd Ed. Philadelphia: Lippincott-Raven; 1998:1485-1508

14. Liu KKW, Lam WWM. Parotid hemangioma in infancy: diagnosis with technetium 99m-labeled red blood cell pool imaging. Otolaryngol Head Neck Surg 1995;112:780-781

15. Laccourreye H, Laccourreye O, Cauchois R, et al. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 1994;104:1487-1494

16. Garden AS, Weber RS, Morrison WG, et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int JRadiat Oncol BiolPhys 1995;32:619

17. Miglianico L, Eschwege F, Marandas P, et al. Cervicofacial adenoid cystic carcinoma: study of 102 cases: influence of radiation therapy. Int J Radiat Oncol Biol Phys 1987;13:673-678

18. North CA, Lee DJ, Piantadosi S, et al. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990;18:1319

19. Pedersen D, Overgaard J, Sogaard H, et al. Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 1992;102:1064-1069

20. Natvig K, Soberg R. Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25-year follow-up study. Head Neck 1994;16:213-217

21. Buchman C, Stringer SP, Mendenhall WM, et al. Pleomorphic adenoma: effect of tumor spill in inadequate resection of tumor recurrence. Laryngoscope 1994;104:1231-1234

22. Adams GL. Malignant tumors of the parotid gland. In: Gates GA, ed. Current Therapy in Otolaryngology—Head and Neck Surgery. 6th Ed. St Louis, MO: CV Mosby; 1998:228-234

23. Medina JE, Byers RM, Maves MD, et al. Clinical Practice Guidelines for Diagnosis and Management of Cancer of the Head and Neck (Parotid). American Society for Head and Neck Surgery and The Society of Head and Neck Surgeons; 1996:65-67

The Parotid Neoplasm


Marshall Strome

Given the remarkable advances during the last decade in our understanding of tumor biology, intracellular ultrastructural aberrations, imaging, radiotherapy delivery, and the synergism of radiotherapy with chemotherapeutic agents, it is remarkable that management controversies facing otolaryngologists 30 years ago remain today for parotid neoplasia. Some issues defy ready resolution in part because prospective data of statistical import are and have been difficult to acquire. It is the rarity and multiplicity of these malignancies that makes the former so. Further, in some instances, accuracy would require a 20-year follow-up period, because of growth characteristics and long intervals before recurrences are identified.

Given the complexities of the diagnosis and management of malignant parotid tumors, differences of opinion are both understandable and inevitable. Questions legitimately disputed are the efficacy and indications for fine-needle aspiration biopsy (FNAB), imaging technology, nerve monitoring, frozen section, surgical extent, facial nerve sacrifice, the use of radiotherapy, and chemotherapy. Classic articles are reviewed in virtually all book chapters and recent articles, with some presenting raw data for reader interpretation, others suggesting a format for management. My approach is to define the issues, followed by a personal philosophy based on an extensive experience with parotid neoplasia.

0 0

Post a comment